Article
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.
The Journal of experimental medicine - 3 Jun 2013
Bibert Stéphanie, Roger Thierry, Calandra Thierry, Bochud Murielle, Cerny Andreas, Semmo Nasser, Duong François H T, Gerlach Tilman, Malinverni Raffaele, Moradpour Darius, Negro Francesco, Müllhaupt Beat, Bochud Pierre-Yves
Abstract excerpt
Approximately 3% of the world population is chronically infected with the hepatitis C virus (HCV), with potential development of cirrhosis and hepatocellular carcinoma. Despite the availability of new antiviral agents, treatment remains suboptimal. Genome-wide association studies (GWAS) identifie...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
